节点文献

CSPG4基因在鼻咽癌中的表达分析

CSPG4 Gene Expression in Nasopharyngeal Carcinoma and Control Tissues

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 宋亚莉李小玲黄丽丽李俏孙梦熙张文玲石磊范松青龚朝建喻正源向波彭淑平熊炜阳剑波曾朝阳李桂源

【Author】 Yali SONG~1,Xiaoling LI~1,Lili HUANG~1,Qiao LI~1,Mengxi SUN~1,Wenling ZHANG~2,Lei SHI~3,Songqing FAN~3,Zhaojian GONG~1, Zhengyuan YU~1,Bo XIANG~1,Shuping PENG~1,Wei XIONG~2,Jianbo YANG~1,Zhaoyang ZENG~2,Gui-yuan LI~(1,2) 1 Key Laboratory of Carcinogenesis of Ministry of Health,Key Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education, Cancer Research Institute,Central South University,Changsha 410078,China 2 Hunan Key Laboratory of Non-resolving Inflammation and Cancer,the Third Xiangya Hospital,Central South University,Changsha 410013,China 3 Department of Pathology,the Second Xiangya Hospital,Central South University,Changsha 410011,China

【机构】 中南大学肿瘤研究所,卫生部癌变原理重点实验室,教育部癌变与侵袭原理重点实验室中南大学湘雅三医院湖南省非可控性炎症与肿瘤重点实验室中南大学湘雅二医院病理科中南大学湘雅三医院,湖南省非可控性炎症与肿瘤重点实验室

【摘要】 目的:研究硫酸软骨素多糖蛋白4(CSPG4)基因在鼻咽癌及对照组织中的表达。方法:采用实时荧光定量PCR测定CSPG4基因在4例正常鼻咽上皮和18例鼻咽癌组织(其中Ⅱ期6例,Ⅲ期5例,Ⅳ期7例)中的表达情况;通过构建包含92例对照和187例鼻咽癌的组织芯片,应用免疫组织化学检测CSPG4蛋白的表达和分布。结果:正常鼻咽上皮中CSPG4基因mRNA表达水平较低,在鼻咽癌中CSPG4表达上调且与临床分期呈正相关,差异具有统计学意义(P=0.017)。免疫组织化学结果表明鼻咽癌中CSPG4蛋白表达水平高于对照组,91.98%的鼻咽癌组织中CSPG4为强阳性表达,而对照组的强阳性率为76.09%(P=0.001)结论:CSPG4在鼻咽癌中随着临床进展表达逐渐上调,可能参与了鼻咽癌的发生发展,具体机制及临床应用前景值得进一步深入研究。

【Abstract】 Objective:To study the expression of chondroitin sulfate proteoglycan 4(CSPG4) gene in nasopharyngeal carcinoma(NPC) and control tissues.Methods:The CSPG4 mRNA expression of gene in 4 cases with normal nasopharyngeal epithelial tissue and 18 cases with NPC,including 6 stage-Ⅱ,5 stage-Ⅲ,and 7 stage-Ⅳcases,was determined by real-time quantitative PCR.A tissue microarray containing 92 cases of control and 187 cases of NPC tissues was constructed,and the CSPG4 protein expression level was assayed by immunohistochemistry.Results:CSPG4 mRNA was barely expressed in the normal tissues of nasopharyngeal epithelium,but significantly upregulated in the NPC biopsies(P=0.017) and positively correlated with the NPC clinical stage.The CSPG4 protein expression was also higher in NPC than in the controls.CSPG4 was significantly expressed in 91.98%of NPC cases,whereas the percentage of high CSPG4 expression cases was 76.09%in the control group(P=0.001).Conclusion:The CSPG4 gene is upregulated in NPC biopsies and is directly associated with NPC clinical staging,implying the probable involvement of CSPG4 in the development of NPC.The detailed mechanism of CSPG4 in carcinogenesis and its potential clinical application in NPC should be investigated further.

【基金】 湖南省自然科学基金(编号:10JJ7003)资助;supported by the National Natural Science Foundation of China(Nos.30871282,30871365,81172189,81171930,and 81272298);the Fok Ying Tong Education Foundation(121036);the Fundamental Research Funds for the Central South Universities(2011JQ020);the Mittal Innovative Entrepreneurial Project ofCentral South University(11MX27)~~
  • 【文献出处】 中国肿瘤临床 ,Chinese Journal of Clinical Oncology , 编辑部邮箱 ,2012年24期
  • 【分类号】R739.63
  • 【被引频次】4
  • 【下载频次】158
节点文献中: